proprietary name


Also found in: Dictionary, Thesaurus, Legal, Financial, Encyclopedia, Wikipedia.

pro·pri·e·tar·y name

(prō-prī'ĕ-tār'ē nām),
The protected brand name or trademark, registered with the U.S. Patent Office, under which a manufacturer markets its product. It is written with a capital initial letter and is often further distinguished by a superscript R in a circle (®). Compare: generic name, nonproprietary name.
[L. proprietas, ownership]

proprietary name

n.
The patented brand name or trademark under which a manufacturer markets a product.

proprietary name

A commercial name granted by a naming authority for use in marketing a drug/device product in a particular jurisdiction.

pro·pri·e·tar·y name

(prŏ-prīĕ-tar-ē nām)
The protected brand name or trademark, registered with the U.S. Patent Office, under which a manufacturer markets a product. It is written with an initial capital letter, if appropriate, and is often further distinguished by a register mark (®).
Compare: generic name, nonproprietary name
[L. proprietas, ownership]

proprietary name

commercial drug name

pro·pri·e·tar·y name

(prŏ-prīĕ-tar-ē nām)
Protected brand name or trademark, registered with the U.S. Patent Office (or other governmental authority), under which a manufacturer markets its product. It is written with a capital initial letter and is often further distinguished by a superscript R in a circle (®).
[L. proprietas, ownership]
References in periodicals archive ?
Nevertheless, the guidance paper provided background information which showed the link between medication errors and proprietary name selection within the medication use system.
THE POSITIVE--QUICKER REVIEW OF PROPRIETARY NAME APPLICATIONS AND GUIDANCE
However, the work entailed in testing a proprietary name for submission to the FDA could cost well into the hundreds of thousands of dollars.
145) For the proprietary name review process, the gold standard has yet to be established.
97, 122 ("the proprietary name is an unsleeping salesman that ceaselessly promotes the product and therefore, should pack as much recognition and recall value as possible" (quoting from a presentation given on behalf of The Brand Institute)); James L.
See Herberholz, supra note 6, at 123-24 (suggesting that if there was an examining procedure which provides a framework as to how a potential proprietary name were reviewed on par with the Trademark Office's Trademark Manual of Examination Procedures ("TMEP"), the process would be more transparent for the pharmaceutical industry).
PDUFA Pilot Project Proprietary Name Review Concept Paper, U.
29, 1999) (stating that shipping a drug product to an investigator during clinical trials with labeling which includes the potential proprietary name constitutes use in the pharmaceutical context).
Originally, Pharmacia & Upjohn planned to market the drug under the proprietary name, REGAIN, which gained registration at the USPTO.
Pilot Program to Evaluate Proposed Proprietary Name Submissions; Procedures to Register for Participation and Submit Data, 73 Fed.